Pakistan Healthcare Jinnah Complex
The Government of Pakistan has announced the establishment of the Jinnah Medical Complex and Research Center (JMC&RC) in Islamabad, positioning the new greenfield healthcare facility as a world-class medical institution and national Center of Excellence while creating significant near-term export opportunities for U.S. medical technology, digital health, and clinical systems suppliers.
The project will include a 1,200-bed tertiary and quaternary care hospital, supported by advanced clinical, diagnostic, research, and teaching facilities meeting international standards. Implementation of the project will be carried out in phases between 2026 and 2029, in coordination with Islamabad’s Capital Development Authority (CDA) and under the oversight of the Jinnah Medical Complex Board of Directors.
The JMC&RC is envisioned as an integrated medical campus delivering tertiary care, specialized diagnostics, advanced surgical services, and high-quality research and teaching functions. The project aims to integrate leading international medical technologies with global best practices in medical education and research. Its overarching objective is to strengthen Pakistan’s healthcare capacity, promote medical innovation, and address Pakistan’s complex national health challenges.
The project will require advanced medical technologies, digital health systems, automation, laboratory equipment, patient care infrastructure, and comprehensive training support. There are ten planned Centers of Excellence, including cardiothoracic care, oncology, neuroscience, transplantation, pediatrics, emergency medicine, and major surgical specialties, each fully integrated with inpatient, outpatient, critical care, and diagnostic services. Much of the medical equipment and services that will be required to build out the campus and its facilities will need to be acquired from international sources, or from Pakistan distributors of international offerors.
The Government of Pakistan has approved a basic project budget of approximately $750 million. Implementation will proceed in two phases: Phase I will deliver the hospital facility, followed by Phase II, which will include a medical college and related facilities. The Capital Development Authority has allocated over 74 acres of land for the complex in Islamabad.
Procurement of Medical Equipment
The procurement of medical equipment for the complex is planned as follows:
A. Phase 1 A (Facilities and Equipment to support 100 beds) – Expected completion date: June 2027.
B. Phase 1 B (Facilities and Equipment to support an additional 300 beds) – Expected completion date: December 2027.
C. Phase 1 (Facilities and Equipment to support an additional 800 beds) – This final phase will result in the full 1,200 bed capacity being available.: Expected completion date: December 2029.
Opportunities for U.S. Companies
The project is estimated to include $200 million in medical equipment procurement, presenting substantial commercial opportunities for U.S. medical technology suppliers. There will be a significant demand for advanced biomedical equipment across radiology, nuclear medicine, surgical services, critical care, and neonatal care. Key equipment requirements include:
- Diagnostic Imaging & Radiology: MRI Scanner 3T, CT Scanner, Mammography System, DEXA Scanner, Ultrasound Machines (multiple units), C-Arm Fluoroscopy Unit.
- Nuclear Medicine & Advanced Imaging: Linear Accelerator (LINAC), CyberKnife Radiosurgery System, Gamma Camera, Brachytherapy System, Cyclotron (small-scale), CT Simulator, PET-CT Scanner, SPECT Scanner.
- Operating Room & Surgical Technologies: Robotic Surgery System, Endoscopy and minimally invasive surgery platforms, C-Arm imaging systems (integrated with OR), Operating room equipment, Dialysis, Patient monitoring, Infusion systems.
- Critical Care, Neonatal, and General Equipment: Anesthesia Machines, Ventilators (adult & neonatal), Infant Incubators, Infant Warmers, Phototherapy Units, ECG Machines, Defibrillators.
U.S. firms are recognized globally for their high standards, reliability, and cutting-edge innovation, making them well-positioned to compete for these procurement packages. The project also provides potential for long-term collaboration through technology transfer, capacity-building, and research partnerships with the Complex’s academic and clinical divisions.
For further information and to discuss your offers for consideration by JMC&RC, please contact; Ayan Ali Khan - Senior Commercial Specialist at AyanAli.Khan@trade.gov and Muhammad Ayaz Khan – Commercial Specialist at Muhammad.Ayazkhan@trade.gov .